RecruitingPHASE2, PHASE3NCT06252961

A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects

Studying Loiasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Programme National de Lutte contre l'Onchocercose, Republic of the Congo
Principal Investigator: Jéremy CAMPILLO, PharmD PhD
Institut de Recherche pour le Développement (IRD)
Intervention: Levamisole 3 days(drug)
Enrollment: 99 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2024 – 2026

Study locations (2)

Supervisor, Sibiti, Komono, Republic of the Congo
General Supervisor, Sibiti, Mokassi, Republic of the Congo

Collaborators

Institut de Recherche pour le Developpement

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06252961 on ClinicalTrials.gov

← Back to all trials